| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 03/22/2006 | EP1636252A1 Statine derivatives for the treatment of alzheimer s disease |
| 03/22/2006 | EP1636250A2 Self-assembling peptides incorporating modifications and methods of use thereof |
| 03/22/2006 | EP1635866A2 Modified antiviral peptides with increased activity and cell membrane affinity |
| 03/22/2006 | EP1635858A2 Targeted delivery to legumain-expressing cells |
| 03/22/2006 | EP1635855A2 Selective r-cadherin antagonists and methods |
| 03/22/2006 | EP1635692A2 Monitoring immunologic, hematologic and inflammatory diseases |
| 03/22/2006 | EP0915700B1 Use of beta-sheet mimetics as protease and kinase inhibitors and as inhibitors of transcription factors |
| 03/22/2006 | CN1750841A CLK-peptide and SLK-peptide |
| 03/22/2006 | CN1749270A Polypeptide combined with T cell surface co-stimulation molecule CD137 and its use |
| 03/22/2006 | CN1749269A Serial derivatization of peptides for de novo sequencing using tandem mass spectrometry |
| 03/22/2006 | CN1246456C Lactic acid bacteria capable of reducing individual's tendency to develop allergic reactions |
| 03/21/2006 | USRE39034 synthetic polypeptides used to control semen binding to oocytes; fertility and/or antifertility agents |
| 03/21/2006 | US7015306 Peptide analogs of neurotensin resistant to enzymatic degradation and retain high binding affinity for neurotensin receptors; metal chelating group on one end; replacing Arg8 with Gly(PipAm) ((N-amidinopiperidinyl)glycine) for example; useful for diagnostic and therapeutic purposes |
| 03/21/2006 | US7015196 neurokinin receptor inhibitors comprising cyclic petides used for prophylaxis of respiratory system and urogenital disorders, as antitussive agents and muscle relaxants |
| 03/16/2006 | WO2006028160A1 S-oligonucleotide conjugate and antisense agent |
| 03/16/2006 | WO2005121168A3 Heparin binding peptide |
| 03/16/2006 | WO2005094870A3 Use of osteopontin fragment svvglr-derived peptides for the treatment of ischemic diseases |
| 03/16/2006 | US20060058512 Process for producing humanized chimera antibody |
| 03/16/2006 | US20060058504 Peptides capable of inducing attraction to the axonal growth and their use for treating neurodegenerative diseases |
| 03/16/2006 | US20060058240 Peptides and compounds that bind to a receptor |
| 03/16/2006 | US20060058228 nine amino acid, disulfide-constrained peptide that selectively bound and was internalized into colon cancer cells; exhibit decreased or a substantially nonexistent immunogenicity in an in vivo system |
| 03/16/2006 | US20060057668 Antimicrobial polypeptide and utilization thereof |
| 03/16/2006 | US20060057156 Materials and methods for inductions of immune tolerance |
| 03/16/2006 | US20060057139 Process for producing humanized chimera antibody |
| 03/16/2006 | US20060057099 Ph-sensitive polymeric conjugates of an anthracycline cancerostatic drug for targeted therapy |
| 03/16/2006 | US20060057064 Useful in SPECT image diagnosis, PET image diagnosis, MRI image diagnosis and the like, for imaging sites of inflammation |
| 03/16/2006 | DE102004038134A1 New multivalent chelator compounds containing a carbohydrate scaffold structure linked to chelator groups and coupling groups useful for modification and/or immobilization of target molecules e.g. proteins that carry an affinity-tag |
| 03/16/2006 | DE102004035978A1 New aminoadamantane derivatives useful for treating e.g. viral diseases, Parkinson's disease, Huntington's chorea, Alzheimer's disease, autism, tinnitus, Tourette syndrome, hypertension, sleep disorders and psychosis |
| 03/16/2006 | CA2579547A1 Novel peptides and methods for the treatment of inflammatory disease |
| 03/16/2006 | CA2577731A1 Peptide-based body surface reagents for personal care |
| 03/16/2006 | CA2575997A1 Carrier conjugates of gnrh-peptides |
| 03/15/2006 | EP1634949A1 Method for generating activated T-cells and antigen-pulsed antigen-presenting cells |
| 03/15/2006 | EP1633780A2 Control of lactation and peptides therefore |
| 03/15/2006 | EP1633773A2 D-amino acid peptides |
| 03/15/2006 | EP1633381A2 Assays using amyloid precursor proteins with modified beta-secretase cleavage sites to monitor beta-secretase activity |
| 03/15/2006 | EP1196429B1 Process for the deprotection of protected thiols |
| 03/15/2006 | EP1179059B1 Isolating biological modulators from biodiverse gene fragment libraries |
| 03/15/2006 | CN1747967A Peptide conjugate |
| 03/15/2006 | CN1747966A Peptidic sulfonamides |
| 03/15/2006 | CN1746182A Design of antisuppository KGD-cyclohepta-peptide, its preparation and use thereof |
| 03/15/2006 | CN1746181A Coronavirus specific T-cellantigen determinate cluster |
| 03/14/2006 | US7012128 Interaction between cyclin D1 and steroid receptor co-activators and uses thereof in assays |
| 03/14/2006 | US7012066 for coadministration with interferon and antiviral agent |
| 03/14/2006 | US7012065 Cyclosporins for the treatment of immune disorders |
| 03/14/2006 | US7012064 Cyclosporins for the treatment of immune disorders |
| 03/14/2006 | US7011834 Immunomodulating dimers |
| 03/14/2006 | CA2324348C Methods and compositions for peptide synthesis |
| 03/09/2006 | WO2006024694A2 Peptide inhibitors of hk2 and their use |
| 03/09/2006 | WO2005123759A8 Fgfr binding peptides |
| 03/09/2006 | WO2005122379A9 Alpha-4 beta-1 integrin ligands for imaging and therapy |
| 03/09/2006 | WO2005082927A3 Antihypertensive peptides |
| 03/09/2006 | US20060052307 Bone growth factor |
| 03/09/2006 | US20060052290 Cyclosporine derivatives are disclosed which possess enhanced efficacy and reduced toxicity over naturally occurring and other presently known cyclosporins and cyclosporine derivatives. The cyclosporine derivatives of the present invention are produced by chemical and isotopic substitution |
| 03/09/2006 | US20060052285 Induction of mitochondrial membrane permeabilization via the physical and functional interaction of the HIV-1 Vpr protein with the mitochondrial inner membrane protein ANT (also called adenine nucleotide translocase or ADP/ATP carrier) |
| 03/09/2006 | US20060052283 The Sperm Binding Ligand HIPRTY and Its Involvement in Embryo Cleavage |
| 03/09/2006 | US20060051878 Nano-sized optical fluorescence labels and uses thereof |
| 03/09/2006 | US20060051877 Fibronectin biopolymer marker indicative of insulin resistance |
| 03/09/2006 | US20060051811 Site-specific labelling of proteins using acridone and quinacridone lifetime dyes |
| 03/09/2006 | US20060051352 CEA binding agents and compositions to reverse CEA-mediated tumorigenic effects on human cancer cells, restore sensitivity to drug induced apoptosis and uses thereof |
| 03/08/2006 | EP1632502A1 Methods of detecting collagen degradation in vivo |
| 03/08/2006 | EP1632470A2 Calcium receptor active molecules |
| 03/08/2006 | EP1631674A2 Peptide ligands of dendritic cells for nucleic acid vector targeting |
| 03/08/2006 | EP1631585A1 Tumor antigens for prevention and/or treatment of cancer |
| 03/08/2006 | EP1631313A2 Combination therapy for b cell disorders |
| 03/08/2006 | EP1631309A2 Protein kinase c peptides for use in withdrawal |
| 03/08/2006 | EP1290013B1 Apo-ai/aii peptide derivatives |
| 03/08/2006 | EP1102776B1 Water soluble prodrugs of hindered phenols |
| 03/08/2006 | EP1003774B1 GnRH ANTAGONISTS BEING MODIFIED IN POSITIONS 5 AND 6 |
| 03/08/2006 | EP0907312B1 Compositions and methods for taxol biosynthesis |
| 03/08/2006 | EP0804480B1 Purified thrombopoietin and method of making it |
| 03/08/2006 | CN1745094A Peptides, antibodies thereto, and their use in the treatment of central nervous system damage |
| 03/08/2006 | CN1744954A Biological control of nanoparticles |
| 03/08/2006 | CN1744909A Orally administered peptides synergize statin activity |
| 03/08/2006 | CN1244376C Releasable bond and composition containing said bond |
| 03/07/2006 | US7009036 Peptide inhibiting platelet derived growth factor (PDGF-BB) and fibroblast growth factor (bFGF) activity |
| 03/07/2006 | US7009035 Peptide for use in the diagnosis and treatment of tumors |
| 03/07/2006 | US7008928 Crystals of N2-(N,N-dimethyl-L-valyl)-N-[(1S,2R)-2-methoxy-4-[(2S)-2-[(1R,2R)-1-methoxy-2-methyl-3-oxo-3-[(2-phenylethyl)amino]propyl]-1-pyrrolidinyl]-1-[(S)-1-methylpropyl]-4-oxobutyl]-N-methyl-L-valinamide with potent antitumor activity |
| 03/07/2006 | US7008922 Transplantation antigen that can lead to rejection of HLA-matched male organ and bone marrow grafts by female recipients, and may play a role in pregnancy and spermatogenesis. However, the origin and function of H-Y |
| 03/07/2006 | US7008779 novel gene and protein designated PHELIX; in normal individuals, expressed only in testis, but expressed at high levels in advanced and metastatic prostate cancer, and expressed at lower levels in testicular, bladder, ovarian cancers |
| 03/07/2006 | US7008622 Methods and compositions for impairing multiplication of HIV-1 |
| 03/02/2006 | WO2006023452A2 Cyclosporin analogs for the treatment of immunoregulatory disorders and respiratory diseases |
| 03/02/2006 | WO2005121164A9 Process for the preparation of peptides |
| 03/02/2006 | WO2005116051A3 Tumor-associated peptides that bind to mhc-molecules |
| 03/02/2006 | WO2005071414A3 Kit for immobilizing organic substance, organic substance-immobilized structure, and manufacturing methods therefor |
| 03/02/2006 | WO2005070827A3 Fullerene based amino acids |
| 03/02/2006 | WO2005023836A3 Peptide-based diblock and triblock dispersants and diblock polymers |
| 03/02/2006 | WO2005000351A3 Combination therapy for b cell disorders |
| 03/02/2006 | WO2004092332A3 Sars virus polypeptides |
| 03/02/2006 | US20060046303 Method of eliminating phosphate group of peptide and method of analyzing peptide |
| 03/02/2006 | US20060046255 Use of nucleic acid analogues in diagnostics and analytical procedures |
| 03/02/2006 | US20060045879 Antibodies which are directed against the Marburg I polymorphism of factor VII-activating protease (FSAP), and their preparation and use |
| 03/02/2006 | DE102005026163A1 Gegen den Marburg I Polymorphismus der Faktor VII aktivierenden Protease (FSAP) gerichtete Antikörper, ihre Herstellung und Verwendung Against the Marburg I polymorphism of the factor VII-activating protease (FSAP) Antibodies, their production and use |
| 03/01/2006 | EP1630171A1 Streptavidin binding peptides |
| 03/01/2006 | EP1630170A1 A method of generating a crystal of a molecule-of-interest and a kit therefor |
| 03/01/2006 | EP1630169A2 Intermediates for LHRH antagonist synthesis, process for their production, and process for LHRH antagonist production |
| 03/01/2006 | EP1629007A2 Novel peptides that bind to the erythropoietin receptor |
| 03/01/2006 | EP1629002A1 Methods for synthesizing conformationally constrained peptides, peptidometics and the use thereof as synthetic vaccines |
| 03/01/2006 | EP1629001A2 Blys antagonists and uses thereof |
| 03/01/2006 | EP1629000A2 Macrocyclic isoquinoline peptide inhibitors of hepatitis c virus |
| 03/01/2006 | EP1628994A2 Method for identifying modulators of g protein coupled receptor signaling |